Bio-Rad Laboratories, Inc. (FRA:BUWA)
Germany
· Delayed Price · Currency is EUR 272.10
-1.40 (-0.51%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 1.04B | 1.04B |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Revenue | 860.90M | 834.10M |
Log In |
Log In |
Log In | Upgrade
|
| APAC Revenue | 497.80M | 521.60M |
Log In |
Log In |
Log In | Upgrade
|
| Other Regional Revenue | 162.00M | 169.30M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.56B | 2.57B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Life Science Revenue | 1.03B | 1.03B |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Revenue | 1.53B | 1.54B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Revenue | - | 500.00K |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.56B | 2.57B |
Log In |
Log In |
Log In | Upgrade
|
Gross Profit
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Life Science Segment Profit | - | 582.40M |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Segment Profit | - | 796.60M |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Segment Profit | - | -100.00K |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Other) | 1.34B | - |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Total) | 1.34B | 1.38B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Life Science Operating Profit | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Operating Profit | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Operating Profit | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | 224.40M | 269.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 224.40M | 269.00M |
Log In |
Log In |
Log In | Upgrade
|